Table 4 Analysis of prognostic factors for breast cancer by Cox multivariate analysis
From: Significance of ERβ expression in different molecular subtypes of breast cancer
Variances | Regression coefficient | Standard error | Wald value | P value | OR value | 95.0% confidence intervals | |
|---|---|---|---|---|---|---|---|
Clinical staging | 22.570 | 0.000* | |||||
Stage I | -1.807 | 0.402 | 20.205 | 0.000* | 0.164 | 0.075 | 0.361 |
Stage II | -0.897 | 0.271 | 10.976 | 0.001* | 0.408 | 0.240 | 0.693 |
ERβ expression | -0.732 | 0.303 | 5.834 | 0.016* | 0.481 | 0.266 | 0.871 |
ERα expression | 0.074 | 0.286 | 0.067 | 0.795 | 1.077 | 0.615 | 1.888 |
PR expression | 0.518 | 0.315 | 2.704 | 0.100 | 1.679 | 0.905 | 3.115 |
Her-2 expression | -0.108 | 0.242 | 0.199 | 0.656 | 0.898 | 0.559 | 1.442 |
Chemotherapy | -1.096 | 0.326 | 11.337 | 0.001* | 0.334 | 0.177 | 0.633 |
Radiotherapy | -0.515 | 0.270 | 3.648 | 0.056 | 0.597 | 0.352 | 1.014 |
Endocrine therapy | -0.016 | 0.279 | 0.003 | 0.954 | 0.984 | 0.570 | 1.700 |